Related Experiment Video
Updated: Sep 30, 2026

Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice
Published on: February 3, 2016
Double-blind placebo-controlled trial of secretin: effects on aberrant behavior in children with autism
Tracy Carey1, Karen Ratliff-Schaub, Jeanne Funk
1Department of Pediatrics, Medical College of Ohio, Toledo 43608, USA. TCarey@mc.edu
Abstract:
Secretin has been proposed as a treatment alternative for autistic spectrum disorders, but empirical support is lacking. A double-blind placebo-controlled study examined the effect of a single dose of synthetic human secretin on aberrant behavior. Parent and teacher data from the Aberrant Behavior Checklist for eight male children were analyzed for reliable change in a clinical replication series. By parent and teacher report, the majority of change occurred either on the placebo trial or reflected deterioration subsequent to secretin infusion. Repeated-measures multivariate analysis of variance results were similar. Results are consistent with other studies, suggesting that secretin may not be an effective treatment option.
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Blind Procedures
Blinding
Behavior Modification
A real-world application of operant conditioning principles is applied...
Operant Conditioning Intervention
In operant conditioning, behaviors that are...